A new study found that the most educated are the least likely to get jabbed Authors: RAY HALL The percentage of each education group that is somewhat vaccine hesitant. Source: Carnegie Mellon University There has been much debate over how to get the unvaccinated to get their jabs — shame them, bribe them persuade them, or treat them as victims […]
Authors: King’s College London Symptoms for early COVID-19 infection differ among age groups and between men and women, new research has found. These differences are most notable between younger age groups (16 to 59 years) compared to older age groups (60 to 80 years and over), and men have different symptoms compared to women in […]
Authors: CDC Rate ratios compared to 18- to 29-year-olds1 0-4 years old 5-17 years old 18-29 years old 30-39 years old 40-49 years old 50-64 years old 65-74 years old 75-84 years old 85+ years old Cases2 <1x 1x Reference group 1x 1x 1x 1x 1x 1x Hospitalization3 <1x <1x Reference group 2x 2x 4x 6x 9x 15x Death4 <1x <1x Reference group […]
Authors: Lyudmyla Kompaniyets, PhD1; Audrey F. Pennington, PhD1; Alyson B. Goodman, MD1,2; Hannah G. Rosenblum, MD1,3; Brook Belay, MD1; Jean Y. Ko, PhD1,2; Jennifer R. Chevinsky, MD1,3; Lyna Z. Schieber, DPhil, MD1; April D. Summers, MPH1; Amy M. Lavery, PhD1; Leigh Ellyn Preston, DrPH1; Melissa L. Danielson, MSPH1; Zhaohui Cui, PhD1; Gonza Namulanda, DrPH1; Hussain […]
Authors: Kate E. Mason*, Gillian Maudsley, Philip McHale, Andy Pennington, Jennifer Day and Ben Barr Objectives: Early in the COVID-19 pandemic, people with underlying comorbidities were overrepresented in hospitalised cases of COVID-19, but the relationship between comorbidity and COVID-19 outcomes was complicated by potential confounding by age. This review therefore sought to characterise the international evidence base available in the early stages […]
Authors: Karla Romero Starke 1, Gabriela Petereit-Haack 2, Melanie Schubert 1, Daniel Kämpf 1, Alexandra Schliebner 1, Janice Hegewald 1, Andreas Seidler 1 Abstract Increased age appears to be a strong risk factor for COVID-19 severe outcomes. However, studies do not sufficiently consider the age-dependency of other important factors influencing the course of disease. The aim of this review was to quantify the isolated effect of age on […]
Authors: FDA The U.S. Food and Drug Administration (FDA) is alerting clinical laboratory staff and health care providers that false positive results can occur with antigen tests, including when users do not follow the instructions for use of antigen tests for the rapid detection of SARS-CoV-2. Generally, antigen tests are indicated for the qualitative detection […]
Diagnostic tests are used to detect current, active infections of the SARS-CoV-2 virus. Diagnostic tests can be antigen based (“rapid antigen” tests), which look for protein markers on the outside of the virus, or they can be molecular based (including PCR, LAMP, CRISPR), which look for viral genomic material specific to SARS-CoV-2. Molecular based tests that amplify […]
Authors: Ian W. Pray, PhD1,2,3,*; Laura Ford, PhD1,2,*; Devlin Cole, MD3,4; Christine Lee, PhD1,5; John Paul Bigouette, PhD1,2; Glen R. Abedi, MPH1; Dena Bushman, MSN, MPH1,2; Miranda J. Delahoy, PhD1,2; Dustin Currie, PhD1,2; Blake Cherney, MS1; Marie Kirby, PhD1; Geroncio Fajardo, MD1; Motria Caudill, PhD1,6; Kimberly Langolf, MS7; Juliana Kahrs, MS7; Patrick Kelly, MD4,8; Collin […]
Authors: CDC Summary of Recent Changes Updates as of May 13, 2021 Updated guidance based on new published studies on antigen test performance. Clarification about which NAATs should be used for confirmatory testing. Considerations for people who have had previous SARS-CoV-2 infections and those who have been fully vaccinated. Two new antigen testing algorithms, one […]
